Title : Cardiovascular event reduction and adverse events among subjects attaining low-density lipoprotein cholesterol <50 mg/dl with rosuvastatin. The JUPITER trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin).

Pub. Date : 2011 Apr 19

PMID : 21492764






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 CONCLUSIONS: Among adults with LDL-C &lt;130 mg/dl and high-sensitivity C-reactive protein &gt;=2 mg/l, rosuvastatin-allocated participants attaining LDL-C &lt;50 mg/dl had a lower risk of cardiovascular events without a systematic increase in reported adverse events. Rosuvastatin Calcium C-reactive protein Homo sapiens